A Pilot Study to Evaluate the Efficacy of Ariva® Silver Wintergreen, a Smoking Aversive Lozenge

Completed · Phase 1 · Has a placebo group

Conditions studied: Tobacco Use Disorder, Smoking

In brief

This is a study to determine the safety and effectiveness of silver salt in Ariva® Silver Wintergreen Lozenge on discouraging smoking, by its imparting an unfavorable taste to the smoker when tobacco is smoked.

Key facts

Study ID

NCT01336816

Run by

Star Scientific, Inc

People needed

43

Starts

2009-07-01

Expected to finish

2009-07-01

Last updated by the study team

2014-10-24

Who can join

Age: 23 and older, up to 72. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy adult smoker
• smoking for at least 5 years
• smoking at least one (1) pack of cigarettes a day
• interest in quitting smoking

You may not qualify if…

• known allergy to silver or silver salts
• pregnant or breast-feeding
• current drug or alcohol abuse, and/or history of drug or alcohol dependence within 3 months of study

Where it is running

• Comfort Inn — Martinsburg, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.